source
- Compass Pathways reports six-month durability of response in pivotal psilocybin depression trialCompass Pathways announced that patients in the second of its two pivotal psilocybin trials for depression continued to show a therapeutic response for at least six months. The durability data sugg…
- Digital health firms eye CMS ACCESS Medicare pilot despite modest reimbursementA new Medicare initiative called CMS ACCESS is being launched to manage chronic diseases among seniors. The program will contract digital health companies to provide remote monitoring and other se…